ResearcherJiaxing UniversityActive in the last 2 years
Zhongcheng Zhou
Matched on ORCID iD 0000-0002-7067-4006; OpenAlex author ID A5054301254. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2023: 2 papers · 2024: none · 2025: 1 paper
Papers 3
- A novel tRNA-Derived Fragment, tRF-23-Z87HFK8SDZ inhibits malignant progression of pancreatic cancer through mediating IRS1. Co-author DOI 10.1016/j.abb.2025.110624↗
- CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein. Co-author DOI 10.1016/j.cellsig.2023.110661↗
- The Role of Noncoding RNA Antisense Transcript of the B-Cell Translocation Gene 3 Regulation of BTG3 in Pancreatic Ductal Adenocarcinoma Tumor Progression. Last author DOI 10.1016/j.curtheres.2023.100700↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yiyu Shen · 2 shared papers, 2023–2025 · strength 0.49
- Paper A novel tRNA-Derived Fragment, tRF-23-Z87HFK8SDZ inhibits malignant progression of pancreatic cancer through mediating … DOI 10.1016/j.abb.2025.110624↗
- Paper CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-me… DOI 10.1016/j.cellsig.2023.110661↗
- Bin Wu · 2 shared papers, 2023–2025 · strength 0.49
- Paper A novel tRNA-Derived Fragment, tRF-23-Z87HFK8SDZ inhibits malignant progression of pancreatic cancer through mediating … DOI 10.1016/j.abb.2025.110624↗
- Paper CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-me… DOI 10.1016/j.cellsig.2023.110661↗
- Liping Zheng · 1 shared paper, 2025 · strength 0.30
- Wei Wang · 1 shared paper, 2025 · strength 0.30
- Jing Chen · 1 shared paper, 2023 · strength 0.19
- Jing Wang · 1 shared paper, 2023 · strength 0.18
- Shaohan Wu · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.